12:00 AM
Dec 14, 2009
 |  BC Week In Review  |  Company News  |  Deals

Biomics Biotechnologies, Zetiq Technologies deal

Biomics received exclusive rights to develop and commercialize Zetiq's CellDetect cervical cancer diagnostic in China for five years. The cell-based in vitro assay that uses...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >